|6th February 2021||Richard Hague||10,091||Payment by withholding||$1.16||$11,705.56|
|16th January 2021||Richard Hague||12,456||Payment by withholding||$1.08||$13,452.48|
|26th December 2020||Richard Hague||5,283||Payment by withholding||$0.70||$3,698.10|
|10th November 2020||Raymond J Land||3,446||Open or private sale||$36.77||$126,709.42|
|30th October 2020||Thomas Finnerty||666||Payment by withholding||$32.62||$21,724.92|
|16th October 2020||Richard Hague||10,546||Payment by withholding||$1.07||$11,284.22|
|8th October 2020||Richard Hague||2,563||Payment by withholding||$1.12||$2,870.56|
|1st October 2020||Susan L N Vogt||14,133||Grant/award etc.||$0.00|
|28th September 2020||Richard Hague||5,283||Payment by withholding||$1.04||$5,494.32|
|3rd September 2020||John B Iii Henneman||9,310||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company. The company develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body.